We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 301-320 of 333 results
  1. A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation

    Forty patients with multiple myeloma scheduled to receive melphalan 200 mg/m 2 followed by autologous stem cell transplantation were randomly assigned...

    K Lilleby, P Garcia, ... W Bensinger in Bone Marrow Transplantation
    Article 24 April 2006
  2. Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies

    Background

    Diarrhoea and constipation are common toxicities of chemotherapy, and both are poorly understood. They are manifestations of alimentary...

    Rachel J. Gibson, Dorothy M. K. Keefe in Supportive Care in Cancer
    Article 08 April 2006
  3. High-dose melphalan (200 mg/m2) supported by autologous stem cell transplantation is safe and effective in elderly (⩾65 years) myeloma patients: comparison with younger patients treated on the same protocol

    Limited information is available on the feasibility and efficacy of autologous stem cell transplantation (ASCT) in multiple myeloma (MM) patients >65...

    E Jantunen, T Kuittinen, ... T Nousiainen in Bone Marrow Transplantation
    Article 03 May 2006
  4. Alimentary mucositis: putting the guidelines into practice

    Background

    The Mucositis Study Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology...

    Michael T. Brennan, Inger von Bültzingslöwen, ... Dorothy Keefe in Supportive Care in Cancer
    Article 19 April 2006
  5. Develo** evidence-based guidelines for management of alimentary mucositis: process and pitfalls

    Introduction

    It is important yet difficult to maintain currency in clinical oncology practice. The emergence of new diagnostic technologies and new...

    Dorothy M. Keefe, Douglas E. Peterson, Mark M. Schubert in Supportive Care in Cancer
    Article 07 April 2006
  6. Reduced-intensity conditioning for acute myeloid leukemia: is this strategy correct

    Allogeneic stem cell transplantation for acute myeloid leukemia (AML) using reduced-intensity conditioning (RIC) is based on the strategy of...

    H M Lazarus, J M Rowe in Leukemia
    Article 27 July 2006
  7. Graft-versus-tumor effects on murine mammary carcinoma in a model of nonmyeloablative haploidentical stem cell transplantation

    Despite a slight decrease in mortality over the last decade, breast cancer still remains a leading cause of cancer-related death in women. Although...

    A Vanclée, M van Gelder, ... G M J Bos in Bone Marrow Transplantation
    Article 17 May 2006
  8. Role of cytokines in the treatment of acute leukemias: a review

    Myeloid growth factors, such as granulocyte colony-stimulating factor and granulocyte–macrophage colony-stimulating factor, have been used to...

    F Ravandi in Leukemia
    Article 23 February 2006
  9. Cutaneous Reactions to Chemotherapy and their Management

    International data from 2002 report 10.9 million new cases of cancer and 6.7 million cancer deaths. Chemotherapy is an essential component in the...

    Angela J. Wyatt, Gregory D. Leonard, Dana L. Sachs in American Journal of Clinical Dermatology
    Article 01 February 2006
  10. A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation

    The aim of this study was to evaluate the safety, tolerability and efficacy of a topical gel containing histamine dihydrochloride (HDC) versus a...

    S Elad, A Ackerstein, ... R Or in Bone Marrow Transplantation
    Article 06 March 2006
  11. Autologous stem cell transplantation in elderly (>60 years) patients with non-Hodgkin's lymphoma: a nation-wide analysis

    Limited experience is available on the feasibility and efficacy of autologous stem cell transplantation (ASCT) in elderly patients with non-Hodgkin's...

    E Jantunen, M Itälä, ... T Nousiainen in Bone Marrow Transplantation
    Article 16 January 2006
  12. Opioids in pain management of blood-related malignancies

    Opioids are basic analgesics used in the treatment of moderate to severe pain in patients affected by blood-related malignancies. They should be...

    Pasquale Niscola, Laura Scaramucci, ... Paolo De Fabritiis in Annals of Hematology
    Article 30 March 2006
  13. Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage

    Intestinal mucositis occurs as a consequence of cytotoxic treatment through multiple mechanisms including induction of crypt cell death (apoptosis)...

    Joanne M. Bowen, Rachel J. Gibson, ... Dorothy M. K. Keefe in Supportive Care in Cancer
    Article 02 February 2006
  14. Abstracts

    Article 04 May 2006
Did you find what you were looking for? Share feedback.